[ad_1]
abridgeA Pittsburgh, Pennsylvania-based company specializing in generative AI for clinical documentation has received an additional $150 million in investment.
The Series C investment is led by Lightspeed Venture Partners, which also joins the company’s board of directors. Other new and existing investors include co-lead Redpoint Ventures, IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Mass General Brigham Artificial Intelligence and Digital Innovation Fund (AIDIF), Kaiser Permanente Ventures and CVS participated. Health Ventures.
This increase comes just four months after a $30 million Series B.
The company plans to use the funding to expand its team and develop foundational models that leverage vast amounts of complex medical data.
Led by CEO and Founder Dr. Shiv Rao, Abridge provides a platform dedicated to medical conversations, improving the efficiency of clinical documentation while allowing clinicians to focus on their patients. Its enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time with deep integration with EMRs. The company’s voice and language technology has been evaluated in 14 of his languages, with functional support for many more. Additionally, its “Linked Evidence” feature, a technology that maps highlighted areas in the synopsis to empirical evidence (and therefore the underlying audio) in the source transcript, has become a must-have feature. The company is actively developing new ways to personalize notes, integrate deeper into the EMR, and provide post-visit insights for clinicians.
Today, Abridge announced a new corporate agreement with Yale New Haven Health System, Connecticut’s largest and most comprehensive health system. This will enable thousands of clinicians to access Abridge for their clinical documentation. Yale New Haven Health has selected Abridge as its generative AI partner in this area of ambient listening. Initial implementation will focus on reducing the cognitive burden of clinical documentation, allowing clinicians to spend more time face-to-face with patients instead of on computers.
financial small business
2024/02/25
[ad_2]
Source link
